Eansor Norman David
SEC CIK 1270905 · EDGAR
BoughtSold
Most active insiders at TECH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Herr Amy E. | Dir | — | $437.2K |
| 2 | Crouse Steven C. | Pres - Diag, Spatial Bi | — | — |
| 3 | Bohnen Shane | SVP - GC | — | — |
| 4 | McManus Matthew | Pres - Diag, Spatial Bio | — | — |
| 5 | Geist William | Pres, PROTEIN SCIENCES | — | — |
| 6 | Klimovsky Judith V. | Dir | — | — |
| 7 | Kelderman Kim | CEO, Dir | — | — |
| 8 | Seth Alpna | Dir | — | — |
| 9 | Vessey Rupert | Dir | — | — |
| 10 | Hippel James | CFO | — | — |
Eansor Norman David made no open-market trades at TECH in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2023-06-08 | 2021-03-25 | MRKR | Marker Therapeutics, Inc. | Eansor Norman David | Dir | G - Gift | $0.00 | +14.3K | 7,142 | New | $0 |
| D | 2023-06-08 | 2021-03-25 | MRKR | Marker Therapeutics, Inc. | Eansor Norman David | Dir | G - Gift | $0.00 | -14.3K | 2,428 | -85% | $0 |
| D | 2023-06-08 | 2021-03-16 | MRKR | Marker Therapeutics, Inc. | Eansor Norman David | Dir | P - Purchase | $17.50 | +14.3K | 16.7K | +588% | +$250.0K |
| DM | 2021-11-16 | 2021-11-12 | TECH | Bio-Techne | Eansor Norman David | Pres-Protein Sciences | S - Sale+OE | $504.00 | -27.2K | 27.3K | -50% | -$13.69M |
| DM | 2021-11-16 | 2021-11-12+ | TECH | Bio-Techne | Eansor Norman David | Pres-Protein Sciences | M - OptEx | $125.05 | +28.0K | 28.5K | +5,387% | +$3.50M |
| 2021-09-02 | 2021-08-31 | TECH | Bio-Techne | Eansor Norman David | Pres-Protein Sciences | S - Sale | $503.07 | -1,538 | 1,318 | -54% | -$773.7K | |
| D | 2021-08-10 | 2021-08-08 | TECH | Bio-Techne | Eansor Norman David | Pres-Protein Sciences | M - OptEx | $0.00 | +2,537 | 3,855 | +192% | $0 |
| D | 2021-08-10 | 2021-08-08 | TECH | Bio-Techne | Eansor Norman David | Pres-Protein Sciences | F - Tax | $481.82 | -999 | 2,856 | -26% | -$481.3K |
Purchase Sale Sale after option exercise All abbreviations